{"version":"1.0","type":"link","title":"Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.","author_name":"Ghiringhelli F 외","author_url":"https://prs-insight.online/author/Ghiringhelli%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167649","thumbnail_width":1200,"thumbnail_height":630}